CANCER [neop]    
preventive [ftcn]    
Plus [ftcn]    
Real [qlco]    
Life [idcn]    
Clinical setting [spco]    
JAPAN [geoa]    
Interim [tmco]    
Study [mnob]    
Conduct [inbe]    
Clarify [acty]    
HEPATOCELLULAR CARCINOMA [neop]    
Contributing [acty]    
occurrence [ftcn]    
Following [tmco]    
Chronic hepatitis C [dsyn]    
Patients [podg]    
RECEIVED [qlco]    
Plus [ftcn]    
Combination Therapy [topp]    
Methods [inpr]    
Patients [podg]    
RECEIVED [qlco]    
Combination Therapy [topp]    
History [ocdi]    
HEPATOCELLULAR CARCINOMA [neop]    
HEPATOCELLULAR CARCINOMA [neop]    
3 Months [tmco]    
Start [tmco]    
treatment [ftcn]    
Observed [ftcn]    
Onset [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
centers [spco]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Observed [ftcn]    
Patients [podg]    
Eligible [idcn]    
Median [spco]    
Duration [tmco]    
YEARS [tmco]    
3 Months [tmco]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
Observed [ftcn]    
YEAR [tmco]    
Cumulative [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
{Non-patient} [clna]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Contributing [acty]    
HEPATOCELLULAR CARCINOMA [neop]    
Selected [acty]    
Therapeutic Efficacy [qlco]    
Sex [orgf]    
ALT [neop]    
WEEKS [tmco]    
End [spco]    
treatment [ftcn]    
Platelet Count [lbpr]    
{Non-patient} [clna]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
ALT [neop]    
Improvement [cnce]    
End [spco]    
treatment [ftcn]    
LOWER [spco]    
YEAR [tmco]    
Cumulative [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
3 4 [fndg]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Indicated [fndg]    
ALT [neop]    
WEEKS [tmco]    
End [spco]    
treatment [ftcn]    
Contributing [acty]    
HEPATOCELLULAR CARCINOMA [neop]    
Several [qnco]    
Known [qlco]    
Risk Factors [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Contribute [acty]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
RECEIVED [qlco]    
Combination Therapy [topp]    
ALT [neop]    
Abnormality [fndg]    
End [spco]    
treatment [ftcn]    
Contribute [acty]    
Onset [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
SUSTAINED VIROLOGIC RESPONSE [fndg]    
Patients [podg]    
